Go to content
UR Home

Drug Repurposing of Metabolic Agents in Malignant Glioma

Seliger, Corinna and Hau, Peter (2018) Drug Repurposing of Metabolic Agents in Malignant Glioma. International Journal of Molecular Sciences 19 (9), p. 2768.

License: Creative Commons Attribution 4.0
Download (237kB)
Date of publication of this fulltext: 22 Nov 2018 08:42

at publisher (via DOI)

Other URL: http://doi.org/10.3390/ijms19092768, https://www.mdpi.com/1422-0067/19/9/2768


Gliomas are highly invasive brain tumors with short patient survival. One major pathogenic factor is aberrant tumor metabolism, which may be targeted with different specific and unspecific agents. Drug repurposing is of increasing interest in glioma research. Drugs interfering with the patient’s metabolism may also influence glioma metabolism. In this review, we outline definitions and methods ...


Export bibliographical data

Item type:Article
Date:14 September 2018
Institutions:Medicine > Lehrstuhl für Neurologie
Projects:Open Access Publizieren (DFG)
Identification Number:
Keywords:glioma; glioblastoma; drug repurposing; metformin; statin; NSAR; disulfiram; lonidamine
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:38072
Owner only: item control page


Downloads per month over past year

  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons